CXD90™ acts on intestinal inflammation
            CXD90™ acts on intestinal inflammation, which is one of the possible underlying causes of IBS. It has :

1. Anti-spasmodic effect

CXD90™ provides relief from painful cramps resulting from spasms by relaxing the smooth muscle of the digestive tract.

2. Anti–inflammatory effect

Over time, CXD90™ helps to manage inflammations, thereby normalising intestinal function.

Inflammatory mediators* refer to COX-II and 5-LOX.

1. Plummer S. M. et al. (1999) Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kB activation via the NIK/IKK signalling complex. Oncogene, 18; 6013-6020

2. Hong J. (2004) Modulation of arachidonic acid metabolism by curcumin and related β-diketone derivatives: effects on cytosolic phospholipase A2, cyclooxygenases and 5-lipoxygenase. Carcinogenesis, 25(9); 1671 – 1679

Previous | Next

Copyright © 2013 by InQpharm Group. All rights reserved. Last updated: July 2013 | ID: MC/TM/EN/13/002
CXD90 and InQpharm are trademarks of the InQpharm group of companies.